Selective molecular recognition in amyloid growth and transmission and cross-species barriers

Journal of Molecular Biology

Volumn 421, Issue 2-3, 2012, Pages 172-184

  Ma, Buyong ^a   Nussinov, Ruth ^a,b  

^a SAIC FREDERICK INC   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Alzheimer's disease; amyloid fibril structures; conformational selection; prion; amyloid oligomers

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; CRYSTALLIZATION; ENUCLEATION; EXPERIMENTATION; HUMAN; HYDROGEN BOND; MOLECULAR BIOLOGY; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN INTERACTION; PROTEIN POLYMERIZATION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW; STRUCTURE ANALYSIS; THEORY;

EID: 84860377014     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.11.023     Document Type: Review

References (106)

1. Carrell R.W., and Lomas D.A. Conformational disease Lancet 350 1997 134 138
2. Kirkitadze M.D., Bitan G., and Teplow D.B. Paradigm shifts in Alzheimer's disease and other neuro degenerative disorders: the emerging role of oligomeric assemblies J. Neurosci. Res. 69 2002 567 577
3. Walsh D.M., and Selkoe D.J. Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration Protein Pept. Lett. 11 2004 213 228
4. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics Science 297 2002 353 356
5. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 489
6. Bitan G. Structural study of metastable amyloidogenic protein oligomers by photo-induced cross-linking of unmodified proteins Methods Enzymol. 413 2006 217 236
7. Luhrs T., Ritter C., Adrian M., Riek-Loher D., Bohrmann B., and Dobeli H. 3D structure of Alzheimer's amyloid-beta(1-42) fibrils Proc. Natl Acad. Sci. USA 102 2005 17342 17347
8. Yoshiike Y., Akagi T., and Takashima A. Surface structure of amyloid-beta fibrils contributes to cytotoxicity Biochemistry 46 2007 9805 9812
9. Xue W.F., Hellewell A.L., Gosal W.S., Homans S.W., Hewitt E.W., and Radford S.E. Fibril fragmentation enhances amyloid cytotoxicity J. Biol. Chem. 284 2009 34272 34282
10. Kayed R., Head E., Sarsoza F., Saing T., Cotman C.W., and Necula M. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers Mol. Neurodegener. 2 2007 18
11. Pitschke M., Prior R., Haupt M., and Riesner D. Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy Nat. Med. 4 1998 832 834
12. Miller Y., Ma B., and Nussinov R. Polymorphism in Alzheimer Aβ amyloid organization reflects conformational selection in a rugged energy landscape Chem. Rev. 110 2010 4820 4838
13. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., and Liosatos M. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins Proc. Natl Acad. Sci. USA 95 1998 6448 6453
14. Barghorn S., Nimmrich V., Striebinger A., Krantz C., Keller P., and Janson B. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease J. Neurochem. 95 2005 834 847
15. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., and Yang A. A specific amyloid-beta protein assembly in the brain impairs memory Nature 440 2006 352 357
16. Hoshi M., Sato M., Matsumoto S., Noguchi A., Yasutake K., Yoshida N., and Sato K. Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta Proc. Natl Acad. Sci. USA 100 2003 6370 6375
17. Noguchi A., Matsumura S., Dezawa M., Tada M., Yanazawa M., and Ito A. Isolation and characterization of patient-derived, toxic, high-mass amyloid {beta}-protein (A{beta}) assembly from Alzheimer's disease brains J. Biol. Chem. 284 2009 32895 32905
18. Eichner T., and Radford S.E. A diversity of assembly mechanisms of a generic amyloid fold Mol. Cell 43 2011 8 18
19. Ansari A., Berendzen J., Bowne S.F., Frauenfelder H., Iben I.E.T., and Sauke T.B. Protein states and protein quakes Proc. Natl Acad. Sci. USA 82 1985 5000 5004
20. Miller D.W., and Dill K.A. Ligand binding to proteins: the binding landscape model Protein Sci. 6 1997 2166 2179
21. Dill K.A., and Chan H.S. From Levinthal to pathways to funnels Nat. Struct. Biol. 4 1997 10 19
22. Ohmine I., Tanaka H., and Wolynes P.G. Large local energy fluctuations in water. II. Cooperative motions and fluctuations J. Chem. Phys. 89 1988 5852 5860
23. Koshland D.E. Application of a theory of enzyme specificity to protein synthesis Proc. Natl Acad. Sci. USA 44 1958 98 104
24. Ma B., Kumar S., Tsai C.J., and Nussinov R. Folding funnels and binding mechanisms Protein Eng. 12 1999 713 720
25. Tsai C.J., Kumar S., Ma B., and Nussinov R. Folding funnels, binding funnels, and protein function Protein Sci. 8 1999 1181 1190
26. Tsai C.J., Ma B., and Nussinov R. Folding and binding cascades: shifts in energy landscapes Proc. Natl Acad. Sci. USA 96 1999 9970 9972
27. Kumar S., Ma B., Tsai C.J., Sinha N., and Nussinov R. Folding and binding cascades: dynamic landscapes and population shifts Protein Sci. 9 2000 10 19
28. Boher D.D., Nussinov R., and Wright P.E. The role of dynamic conformational ensembles in biomolecular recognition Nat. Chem. Biol. 5 2009 789 796
29. Lampe J.N., Brandman R., Sivaramakrishnan S., and de Montellano P.R. Two-dimensional NMR and all-atom molecular dynamics of cytochrome P450 CYP119 reveal hidden conformational substates J. Biol. Chem. 285 2010 9594 9603
30. Henzler-Wildman K.A., Lei M., Thai V., Kerns S.J., Karplus M., and Kern D. A hierarchy of timescales in protein dynamics is linked to enzyme catalysis Nature 450 2007 913 916
31. Kjaergaard M., Teilum K., and Poulsen F.M. Conformational selection in the molten globule state of the nuclear coactivator binding domain of CBP Proc. Natl Acad. Sci. USA 107 2010 12535 12540
32. Ma B., Kumar S., Tsai C.J., Hu Z., and Nussinov R. Transition-state ensemble in enzyme catalysis: possibility, reality, or necessity? J. Theor. Biol. 203 2000 383 397
33. Ma B., and Nussinov R. Enzyme dynamics point to stepwise conformational selection in catalysis Curr. Opin. Chem. Biol. 14 2010 652 659
34. Pan Y., Tsai C.J., Ma B., and Nussinov R. Mechanisms of transcription factor selectivity Trends Genet. 26 2010 75 83
35. Ma B., Tsai C.J., Pan Y., and Nussinov R. Why does binding of proteins to DNA or proteins to proteins not necessarily spell function? ACS Chem. Biol. 5 2010 265 272
36. Yuan P., Liang K., Ma B., Zheng N., Nussinov R., and Huang J. Multiple-targeting and conformational selection in the estrogen receptor: computation and experiment Chem. Biol. Drug Des. 78 2011 137 149
37. Tsai C.J., Ma B.Y., Sham Y.Y., Kumar S., and Nussinov R. Structured disorder and conformational selection Proteins: Struct., Funct., Genet. 44 2001 418 427
38. Gunasekaran K., Tsai C.J., Kumar S., Zanuy D., and Nussinov R. Extended disordered proteins: targeting function with less scaffold Trends Biochem. Sci. 28 2003 81 85
39. Eliezer D. Biophysical characterization of intrinsically disordered proteins Curr. Opin. Struct. Biol. 19 2009 23 30
40. Ma B., Shatsky M., Wolfson H.J., and Nussinov R. Multiple diverse ligands binding at a single protein site: a matter of pre-existing populations Protein Sci. 11 2002 184 197
41. Ma B., Tsai C.J., Haliloglu T., and Nussinov R. Dynamic allostery: linkers are not merely flexible Structure 19 2011 907 917
42. Mackereth C.D., Madl T., Bonnal S., Simon B., Zanier K., and Gasch A. Multi-domain conformational selection underlies pre-mRNA splicing regulation by U2AF Nature 475 2011 408 411
43. Schymkowitz J.W., Rousseau F., Wilkinson H.R., Friedler A., and Itzhaki L.S. Observation of signal transduction in three-dimensional domain swapping Nat. Struct. Biol. 8 2001 888 892
44. Pan Y., Tsai C.J., Ma B., and Nussinov R. How do transcription factors select specific binding sites in the genome? Nat. Struct. Mol. Biol. 16 2009 1118 1120
45. Konuma T., Chatani E., Yagi M., Sakurai K., Ikegami T., Naiki H., and Goto Y. Kinetic intermediates of beta(2)-microglobulin fibril elongation probed by pulse-labeling H/D exchange combined with NMR analysis J. Mol. Biol. 405 2011 851 862
46. Debelouchina G.T., Platt G.W., Bayro M.J., Radford S.E., and Griffin R.G. Intermolecular alignment in beta(2)-microglobulin amyloid fibrils J. Am. Chem. Soc. 132 2010 17077 17079
47. Smith D.P., Woods L.A., Radford S.E., and Ashcroft A.E. Structure and dynamics of oligomeric intermediates in beta(2)-microglobulin self-assembly Biophys. J. 101 2011 1238 1247
48. Pappu R.V., Wang X., Vitalis A., and Crick S.L. A polymer physics perspective on driving forces and mechanisms for protein aggregation Arch. Biochem. Biophys. 469 2008 132 141
49. Qian J., Zhang M., Manners I., and Winnik M.A. Nanofiber micelles from the self-assembly of block copolymers Trends Biotechnol. 28 2010 84 92
50. Jan A., Adolfsson O., Allaman I., Buccarello A.L., Magistretti P.J., and Pfeifer A. Abeta42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta42 species J. Biol. Chem. 286 2011 8585 8596
51. Ruschak A.M., and Miranker A.D. The role of prefibrillar structures in the assembly of a peptide amyloid J. Mol. Biol. 393 2009 214 226
52. Ahmed M., Davis J., Aucoin D., Sato T., Ahuja S., and Aimoto S. Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils Nat. Struct. Mol. Biol. 17 2010 561 567
53. Ma B., and Nussinov R. Polymorphic triple beta-sheet structures contribute to amide H/D exchange protection in Alzheimer's amyloid beta42 peptide J. Biol. Chem. 286 2011 34244 34253
54. Cabriolu R., and Auer S. Amyloid fibrillation kinetics: insight from atomistic nucleation theory J. Mol. Biol. 411 2011 275 285
55. Kashchiev D., and Auer S. Nucleation of amyloid fibrils J. Chem. Phys. 132 2010 215101
56. Liang Y., Lynn D.G., and Berland K.M. Direct observation of nucleation and growth in amyloid self-assembly J. Am. Chem. Soc. 132 2010 6306 6308
57. Cohen S.I., Vendruscolo M., Dobson C.M., and Knowles T.P. Nucleated polymerization with secondary pathways. II. Determination of self-consistent solutions to growth processes described by non-linear master equations J. Chem. Phys. 135 2011 065106
58. Tessier P.M., and Lindquist S. Prion recognition elements govern nucleation, strain specificity and species barriers Nature 447 2007 556 561
59. Corazza A., Rennella E., Schanda P., Mimmi M.C., Cutuil T., and Raimondi S. Native-unlike long-lived intermediates along the folding pathway of the amyloidogenic protein beta2-microglobulin revealed by real-time two-dimensional NMR J. Biol. Chem. 285 2010 5827 5835
60. Pagano K., Bemporad F., Fogolari F., Esposito G., Viglino P., Chiti F., and Corazza A. Structural and dynamics characteristics of acylphosphatase from Sulfolobus solfataricus in the monomeric state and in the initial native-like aggregates J. Biol. Chem. 285 2010 14689 14700
61. Eichner T., Kalverda A.P., Thompson G.S., Homans S.W., and Radford S.E. Conformational conversion during amyloid formation at atomic resolution Mol. Cell 41 2011 161 172
62. Fogolari F., Corazza A., Varini N., Rotter M., Gumral D., and Codutti L. Molecular dynamics simulation of beta-microglobulin in denaturing and stabilizing conditions Proteins 79 2011 986 1001
63. Domanska K., Vanderhaegen S., Srinivasan V., Pardon E., Dupeux F., and Marquez J.A. Atomic structure of a nanobody-trapped domain-swapped dimer of an amyloidogenic beta2-microglobulin variant Proc. Natl Acad. Sci. USA 108 2011 1314 1319
64. 2-microglobulin and its variants Protein Eng. 16 2003 561 575
65. Liu C., Sawaya M.R., and Eisenberg D. beta-microglobulin forms three-dimensional domain-swapped amyloid fibrils with disulfide linkages Nat. Struct. Mol. Biol. 18 2011 49 55
66. Nelson R., and Eisenberg D. Recent atomic models of amyloid fibril structure Curr. Opin. Struct. Biol. 16 2006 260 265
67. Zerovnik E., Stoka V., Mirtic A., Guncar G., Grdadolnik J., and Staniforth R.A. Mechanisms of amyloid fibril formation - focus on domain-swapping FEBS J. 278 2011 2263 2282
68. Rousseau F., Wilkinson H., Villanueva J., Serrano L., Schymkowitz J.W., and Itzhaki L.S. Domain swapping in p13suc1 results in formation of native-like, cytotoxic aggregates J. Mol. Biol. 363 2006 496 505
69. Zerovnik E., Staniforth R.A., and Turk D. Amyloid fibril formation by human stefins: Structure, mechanism & putative functions Biochimie 92 2010 1597 1607
70. Wahlbom M., Wang X., Lindstrom V., Carlemalm E., Jaskolski M., and Grubb A. Fibrillogenic oligomers of human cystatin C are formed by propagated domain swapping J. Biol. Chem. 282 2007 18318 18326
71. Das P., King J.A., and Zhou R. Aggregation of gamma-crystallins associated with human cataracts via domain swapping at the C-terminal beta-strands Proc. Natl Acad. Sci. USA 108 2011 10514 10519
72. Sahoo B., Nag S., Sengupta P., and Maiti S. On the stability of the soluble amyloid aggregates Biophys. J. 97 2009 1454 1460
73. Krebs M.R., Domike K.R., and Donald A.M. Protein aggregation: more than just fibrils Biochem. Soc. Trans. 37 2009 682 686
74. Ma B., and Nussinov R. Polymorphic C-terminal {beta}-sheet interactions determine the formation of fibril or ADDL-like globulomer for the Alzheimer A{beta}42 dodecamer J. Biol. Chem. 286 2010 37102 37110
75. Yu X., and Zheng J. Polymorphic structures of Alzheimer's beta-amyloid globulomers PLoS One 6 2011 e20575
76. Wu J.W., Breydo L., Isas J.M., Lee J., Kuznetsov Y.G., Langen R., and Glabe C. Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation J. Biol. Chem. 285 2010 6071 6079
77. Ma B., and Nussinov R. Simulations as analytical tools to understand protein aggregation and predict amyloid conformation Curr. Opin. Chem. Biol. 10 2006 445 452
78. Petkova A.T., Yau W.M., and Tycko R. Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils Biochemistry 45 2006 498 512
79. Massi F., and Straub J.E. Energy landscape theory for Alzheimer's amyloid beta-peptide fibril elongation Proteins 42 2001 217 229
80. Esler W.P., Stimson E.R., Jennings J.M., Vinters H.V., Ghilardi J.R., and Lee J.P. Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism Biochemistry 39 2000 6288 6295
81. Pease L.F. III, Sorci M., Guha S., Tsai D.H., Zachariah M.R., Tarlov M.J., and Belfort G. Probing the nucleus model for oligomer formation during insulin amyloid fibrillogenesis Biophys. J. 99 2010 3979 3985
82. Aguzzi A., Heikenwalder M., and Polymenidou M. Insights into prion strains and neurotoxicity Nat. Rev., Mol. Cell Biol. 8 2007 552 561
83. Toyama B.H., Kelly M.J., Gross J.D., and Weissman J.S. The structural basis of yeast prion strain variants Nature 449 2007 233 237
84. Sun Y., Makarava N., Lee C.I., Laksanalamai P., Robb F.T., and Baskakov I.V. Conformational stability of PrP amyloid fibrils controls their smallest possible fragment size J. Mol. Biol. 376 2008 1155 1167
85. Makarava N., Lee C.I., Ostapchenko V.G., and Baskakov I.V. Highly promiscuous nature of prion polymerization J. Biol. Chem. 282 2007 36704 36713
86. Wasmer C., Zimmer A., Sabate R., Soragni A., Saupe S.J., Ritter C., and Meier B.H. Structural similarity between the prion domain of HET-s and a homologue can explain amyloid cross-seeding in spite of limited sequence identity J. Mol. Biol. 402 2010 311 325
87. Apostol M.I., Wiltzius J.J., Sawaya M.R., Cascio D., and Eisenberg D. Atomic structures suggest determinants of transmission barriers in mammalian prion disease Biochemistry 50 2011 2456 2463
88. Collinge J., and Clarke A.R. A general model of prion strains and their pathogenicity Science 318 2007 930 936
89. Andreetto E., Yan L.M., Tatarek-Nossol M., Velkova A., Frank R., and Kapurniotu A. Identification of hot regions of the Abeta-IAPP interaction interface as high-affinity binding sites in both cross- and self-association Angew. Chem., Int. Ed. Engl. 49 2010 3081 3085
90. Nicolls M.R. The clinical and biological relationship between type II diabetes mellitus and Alzheimer's disease Curr. Alzheimer Res. 1 2004 47 54
91. Zou W.Q., Xiao X., Yuan J., Puoti G., Fujioka H., and Wang X. Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain J. Biol. Chem. 286 2011 15095 15105
92. Guo J.P., Arai T., Miklossy J., and McGeer P.L. Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease Proc. Natl Acad. Sci. USA 103 2006 1953 1958
93. Miller Y., Ma B., and Nussinov R. Synergistic interactions between repeats in tau protein and Abeta amyloids may be responsible for accelerated aggregation via polymorphic states Biochemistry 50 2011 5172 5181
94. Giasson B.I., Forman M.S., Higuchi M., Golbe L.I., Graves C.L., and Kotzbauer P.T. Initiation and synergistic fibrillization of tau and alpha-synuclein Science 300 2003 636 640
95. Reis H.J., Mukhamedyarov M.A., Rizvanov A.A., and Palotas A. A new story about an old guy: is Alzheimer's disease infectious? Neurodegener. Dis. 7 2010 272 278
96. Siddiqua A., and Margittai M. Three- and four-repeat Tau coassemble into heterogeneous filaments: an implication for Alzheimer disease J. Biol. Chem. 285 2010 37920 37926
97. Dinkel P.D., Siddiqua A., Huynh H., Shah M., and Margittai M. Variations in filament conformation dictate seeding barrier between three- and four-repeat tau Biochemistry 50 2011 4330 4336
98. Perczel A., Hudaky P., and Palfi V.K. Dead-end street of protein folding: thermodynamic rationale of amyloid fibril formation J. Am. Chem. Soc. 129 2007 14959 14965
99. Berryman J.T., Radford S.E., and Harris S.A. Systematic examination of polymorphism in amyloid fibrils by molecular-dynamics simulation Biophys. J. 100 2011 2234 2242
100. Zanuy D., and Nussinov R. The sequence dependence of fiber organization. A comparative molecular dynamics study of the islet amyloid polypeptide segments 22-27 and 22-29 J. Mol. Biol. 329 2003 565 584
101. Ladiwala A.R., Lin J.C., Bale S.S., Marcelino-Cruz A.M., Bhattacharya M., Dordick J.S., and Tessier P.M. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers J. Biol. Chem. 285 2010 24228 24237
102. Csermely P., Palotai R., and Nussinov R. Induced fit, conformational selection and independent dynamic segments: an extended view of binding events Trends Biochem. Sci. 35 2010 539 546
103. Glabe C.G. Conformation-dependent antibodies target diseases of protein misfolding Trends Biochem. Sci. 29 2004 542 547
104. Haupt C., Bereza M., Kumar S.T., Kieninger B., Morgado I., and Hortschansky P. Pattern recognition with a fibril-specific antibody fragment reveals the surface variability of natural amyloid fibrils J. Mol. Biol. 408 2011 529 540
105. Milojevic J., and Melacini G. Stoichiometry and affinity of the human serum albumin-Alzheimer's Abeta peptide interactions Biophys. J. 100 2011 183 192
106. Alberti S., Halfmann R., King O., Kapila A., and Lindquist S. A systematic survey identifies prions and illuminates sequence features of prionogenic proteins Cell 137 2009 146 158